FOXJ2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.525000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.455800E-01
Normal-vs-Stage2
7.525000E-01
Normal-vs-Stage3
3.078600E-01
Normal-vs-Stage4
4.049200E-01
Stage1-vs-Stage2
3.290600E-01
Stage1-vs-Stage3
5.113000E-01
Stage1-vs-Stage4
1.769160E-01
Stage2-vs-Stage3
2.357400E-01
Stage2-vs-Stage4
1.204160E-01
Stage3-vs-Stage4
1.183250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.252800E-01
Normal-vs-AfricanAmerican
7.799200E-01
Normal-vs-Asian
6.964000E-01
Caucasian-vs-AfricanAmerican
9.627000E-01
Caucasian-vs-Asian
7.104800E-01
AfricanAmerican-vs-Asian
8.293400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.640600E-01
Normal-vs-Female
7.388400E-01
Male-vs-Female
9.162000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.722600E-01
Normal-vs-Age(41-60Yrs)
8.307400E-01
Normal-vs-Age(61-80Yrs)
5.867200E-01
Normal-vs-Age(81-100Yrs)
1.385210E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.130600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.024200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.920980E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.400200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.038800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.485200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.616000E-01
Normal-vs-Daily Drinker
2.359000E-01
Normal-vs-Weekly Drinker
7.377000E-01
Normal-vs-Occasional Drinker
6.975000E-01
Normal-vs-Social Drinker
8.873200E-01
Non Drinker-vs-Daily Drinker
3.922000E-01
Non Drinker-vs-Weekly Drinker
7.228800E-01
Non Drinker-vs-Occasional Drinker
5.843800E-02
Non Drinker-vs-Social Drinker
3.061400E-01
Daily Drinker-vs-Weekly Drinker
2.823200E-01
Daily Drinker-vs-Occasional Drinker
1.040190E-02
Daily Drinker-vs-Social Drinker
1.371810E-01
Weekly Drinker-vs-Occasional Drinker
2.278000E-01
Weekly Drinker-vs-Social Drinker
4.891400E-01
Occasional Drinker-vs-Social Drinker
7.741200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.603900E-02
Normal-vs-Grade 2
1.360400E-02
Normal-vs-Grade 3
2.058300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.574560E-01
Grade 1-vs-Grade 3
1.560350E-01
Grade 1-vs-Grade 4
3.603900E-02
Grade 2-vs-Grade 3
7.962800E-01
Grade 2-vs-Grade 4
1.360400E-02
Grade 3-vs-Grade 4
2.058300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.717200E-01
Normal-vs-NonDiabetic
7.853600E-01
Diabetic-vs-NonDiabetic
3.189000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.560400E-01
Normal-vs-NoPancreatitis
6.888600E-01
Pancreatitis-vs-NoPancreatitis
5.360600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.519800E-01
Normal-vs-N1
7.390200E-01
N0-vs-N1
9.219400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.650800E-01
Normal-vs-TP53-NonMutant
8.237600E-01
TP53-Mutant-vs-TP53-NonMutant
1.916370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
